Global Oripavine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Oripavine Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Poppy Extracted Oripavine
- 1.3.3 Biosynthetic Oripavine
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Oripavine Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Analgesic Drugs
- 1.4.3 Detox Drugs
- 1.4.4 Others
- 1.5 Global Oripavine Market Size & Forecast
- 1.5.1 Global Oripavine Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Oripavine Sales Quantity (2020-2031)
- 1.5.3 Global Oripavine Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Alcaliber
- 2.1.1 Alcaliber Details
- 2.1.2 Alcaliber Major Business
- 2.1.3 Alcaliber Oripavine Product and Services
- 2.1.4 Alcaliber Oripavine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Alcaliber Recent Developments/Updates
- 2.2 Extractas Bioscience
- 2.2.1 Extractas Bioscience Details
- 2.2.2 Extractas Bioscience Major Business
- 2.2.3 Extractas Bioscience Oripavine Product and Services
- 2.2.4 Extractas Bioscience Oripavine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Extractas Bioscience Recent Developments/Updates
- 2.3 Sun Pharmaceutical
- 2.3.1 Sun Pharmaceutical Details
- 2.3.2 Sun Pharmaceutical Major Business
- 2.3.3 Sun Pharmaceutical Oripavine Product and Services
- 2.3.4 Sun Pharmaceutical Oripavine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Sun Pharmaceutical Recent Developments/Updates
- 2.4 Antheia
- 2.4.1 Antheia Details
- 2.4.2 Antheia Major Business
- 2.4.3 Antheia Oripavine Product and Services
- 2.4.4 Antheia Oripavine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Antheia Recent Developments/Updates
3 Competitive Environment: Oripavine by Manufacturer
- 3.1 Global Oripavine Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Oripavine Revenue by Manufacturer (2020-2025)
- 3.3 Global Oripavine Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Oripavine by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Oripavine Manufacturer Market Share in 2024
- 3.4.3 Top 6 Oripavine Manufacturer Market Share in 2024
- 3.5 Oripavine Market: Overall Company Footprint Analysis
- 3.5.1 Oripavine Market: Region Footprint
- 3.5.2 Oripavine Market: Company Product Type Footprint
- 3.5.3 Oripavine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Oripavine Market Size by Region
- 4.1.1 Global Oripavine Sales Quantity by Region (2020-2031)
- 4.1.2 Global Oripavine Consumption Value by Region (2020-2031)
- 4.1.3 Global Oripavine Average Price by Region (2020-2031)
- 4.2 North America Oripavine Consumption Value (2020-2031)
- 4.3 Europe Oripavine Consumption Value (2020-2031)
- 4.4 Asia-Pacific Oripavine Consumption Value (2020-2031)
- 4.5 South America Oripavine Consumption Value (2020-2031)
- 4.6 Middle East & Africa Oripavine Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Oripavine Sales Quantity by Type (2020-2031)
- 5.2 Global Oripavine Consumption Value by Type (2020-2031)
- 5.3 Global Oripavine Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Oripavine Sales Quantity by Application (2020-2031)
- 6.2 Global Oripavine Consumption Value by Application (2020-2031)
- 6.3 Global Oripavine Average Price by Application (2020-2031)
7 North America
- 7.1 North America Oripavine Sales Quantity by Type (2020-2031)
- 7.2 North America Oripavine Sales Quantity by Application (2020-2031)
- 7.3 North America Oripavine Market Size by Country
- 7.3.1 North America Oripavine Sales Quantity by Country (2020-2031)
- 7.3.2 North America Oripavine Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Oripavine Sales Quantity by Type (2020-2031)
- 8.2 Europe Oripavine Sales Quantity by Application (2020-2031)
- 8.3 Europe Oripavine Market Size by Country
- 8.3.1 Europe Oripavine Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Oripavine Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Oripavine Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Oripavine Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Oripavine Market Size by Region
- 9.3.1 Asia-Pacific Oripavine Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Oripavine Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Oripavine Sales Quantity by Type (2020-2031)
- 10.2 South America Oripavine Sales Quantity by Application (2020-2031)
- 10.3 South America Oripavine Market Size by Country
- 10.3.1 South America Oripavine Sales Quantity by Country (2020-2031)
- 10.3.2 South America Oripavine Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Oripavine Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Oripavine Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Oripavine Market Size by Country
- 11.3.1 Middle East & Africa Oripavine Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Oripavine Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Oripavine Market Drivers
- 12.2 Oripavine Market Restraints
- 12.3 Oripavine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Oripavine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Oripavine
- 13.3 Oripavine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Oripavine Typical Distributors
- 14.3 Oripavine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Oripavine market size was valued at US$ 29.8 million in 2024 and is forecast to a readjusted size of USD 37.9 million by 2031 with a CAGR of 3.5% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Oripavine is an opiate alkaloid extracted from the opium poppy (Papaver somniferum), and has analgesic properties similar to morphine. While not used as a medicine itself, oripavine is a key starting material (KSM) for the chemical synthesis of various active pharmaceutical ingredients (APIs) for several essential medicines. This includes the opioid agonists, opioid antagonists, and partial agonists1.
This report is a detailed and comprehensive analysis for global Oripavine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oripavine market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Oripavine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Oripavine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Oripavine market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oripavine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oripavine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alcaliber, Extractas Bioscience, Sun Pharmaceutical, Antheia, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Oripavine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Poppy Extracted Oripavine
Biosynthetic Oripavine
Market segment by Application
Analgesic Drugs
Detox Drugs
Others
Major players covered
Alcaliber
Extractas Bioscience
Sun Pharmaceutical
Antheia
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oripavine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oripavine, with price, sales quantity, revenue, and global market share of Oripavine from 2020 to 2025.
Chapter 3, the Oripavine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oripavine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Oripavine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oripavine.
Chapter 14 and 15, to describe Oripavine sales channel, distributors, customers, research findings and conclusion.